Skip to main content
Top
Published in: Critical Care 1/2013

Open Access 01-02-2013 | Review

Advancing critical care: time to kiss the right frog

Author: Mervyn Singer

Published in: Critical Care | Special Issue 1/2013

Login to get access

Abstract

The greatest advances in critical care over the past two decades have been achieved through doing less to the patient. We have learnt through salutary experience that our burgeoning Master-of-the-Universe capabilities and the oh-so-obvious stratagems instilled in us from youth were often ineffective or even deleterious. This re-education process, however, is far from complete. We are now rightly agonizing over the need for better characterization of pathophysiology, earlier identification of disease processes and a more directed approach to therapeutic intervention. We need to delineate the point at which intrinsic and protective adaptation ends and true harmful pathology begins, and how our iatrogenic meddling either helps or hinders. We need to improve trial design in the heterogeneous populations we treat, and to move away from syndromic fixations that, while offering convenience, have generally proved counterproductive. Importantly, we need to discover a far more holistic approach to patient care, evolving from the prevailing overmedicalized, number-crunching perspective towards a true multidisciplinary effort that embraces psychological as well as physiological well-being, with appropriate pharmacological minimization or supplementation. Complacency, with an unfair apportion of blame on the patient for not getting better, is the biggest threat to continued improvement.
Literature
1.
go back to reference Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342: 1301-1308.CrossRef Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342: 1301-1308.CrossRef
2.
go back to reference Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, National Heart and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354: 2564-2575.CrossRefPubMed Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, National Heart and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354: 2564-2575.CrossRefPubMed
3.
go back to reference Veterans Affairs Total Parenteral Nutrition Cooperative Study Group: Perioperative total parenteral nutrition in surgical patients. N Engl J Med 1991, 325: 525-532.CrossRef Veterans Affairs Total Parenteral Nutrition Cooperative Study Group: Perioperative total parenteral nutrition in surgical patients. N Engl J Med 1991, 325: 525-532.CrossRef
4.
go back to reference Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E, Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999, 340: 409-417. 10.1056/NEJM199902113400601CrossRefPubMed Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E, Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999, 340: 409-417. 10.1056/NEJM199902113400601CrossRefPubMed
5.
go back to reference Kress JP, Pohlman AS, O'Connor MF, Hall JB: Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000, 342: 1471-1477. 10.1056/NEJM200005183422002CrossRefPubMed Kress JP, Pohlman AS, O'Connor MF, Hall JB: Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000, 342: 1471-1477. 10.1056/NEJM200005183422002CrossRefPubMed
6.
go back to reference Girard TD, Kress JP, Fuchs BD, Thomason JWW, Schweickert WD, Pun BT, Taichman DB, Dunn JG, Pohlman AS, Kinniry PA, Jackson JC, Canonico AE, Light RW, Shintani AK, Thompson JL, Gordon SM, Hall JB, Dittus RS, Bernard GR, Ely EW: Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008, 371: 126-134. 10.1016/S0140-6736(08)60105-1CrossRefPubMed Girard TD, Kress JP, Fuchs BD, Thomason JWW, Schweickert WD, Pun BT, Taichman DB, Dunn JG, Pohlman AS, Kinniry PA, Jackson JC, Canonico AE, Light RW, Shintani AK, Thompson JL, Gordon SM, Hall JB, Dittus RS, Bernard GR, Ely EW: Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008, 371: 126-134. 10.1016/S0140-6736(08)60105-1CrossRefPubMed
7.
go back to reference Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987, 317: 653-658. 10.1056/NEJM198709103171101CrossRefPubMed Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987, 317: 653-658. 10.1056/NEJM198709103171101CrossRefPubMed
8.
go back to reference Singer M: Catecholamine treatment for shock-equally good or bad? Lancet 2007, 370: 636-637. 10.1016/S0140-6736(07)61317-8CrossRefPubMed Singer M: Catecholamine treatment for shock-equally good or bad? Lancet 2007, 370: 636-637. 10.1016/S0140-6736(07)61317-8CrossRefPubMed
9.
go back to reference Dial S, Delaney JAC, Barkun AN, Suissa S: Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile -associated disease. JAMA 2005, 294: 2989-2995. 10.1001/jama.294.23.2989CrossRefPubMed Dial S, Delaney JAC, Barkun AN, Suissa S: Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile -associated disease. JAMA 2005, 294: 2989-2995. 10.1001/jama.294.23.2989CrossRefPubMed
10.
go back to reference Herzig SJ, Howell MD, Ngo LH, Marcantonio ER: Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009, 301: 2120-2128. 10.1001/jama.2009.722CrossRefPubMed Herzig SJ, Howell MD, Ngo LH, Marcantonio ER: Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009, 301: 2120-2128. 10.1001/jama.2009.722CrossRefPubMed
11.
go back to reference Stelfox HT, Bates DW, Redelmeier DA: Safety of patients isolated for infection control. JAMA 2003, 290: 1899-1905. 10.1001/jama.290.14.1899CrossRefPubMed Stelfox HT, Bates DW, Redelmeier DA: Safety of patients isolated for infection control. JAMA 2003, 290: 1899-1905. 10.1001/jama.290.14.1899CrossRefPubMed
12.
go back to reference Day HR, Perencevich EN, Harris AD, Gruber-Baldini AL, Himelhoch SS, Brown CH, Dotter E, Morgan DJ: Association between contact precautions and delirium at a tertiary care center. Infect Control Hosp Epidemiol 2012, 33: 34-39. 10.1086/663340PubMedCentralCrossRefPubMed Day HR, Perencevich EN, Harris AD, Gruber-Baldini AL, Himelhoch SS, Brown CH, Dotter E, Morgan DJ: Association between contact precautions and delirium at a tertiary care center. Infect Control Hosp Epidemiol 2012, 33: 34-39. 10.1086/663340PubMedCentralCrossRefPubMed
13.
go back to reference Hypothermia after Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346: 549-556.CrossRef Hypothermia after Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346: 549-556.CrossRef
14.
go back to reference Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346: 557-563. 10.1056/NEJMoa003289CrossRefPubMed Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346: 557-563. 10.1056/NEJMoa003289CrossRefPubMed
15.
go back to reference Pfeifer R, Jung C, Purle S, Lauten A, Yilmaz A, Surber R, Ferrari M, Figulla HR: Survival does not improve when therapeutic hypothermia is added to post-cardiac arrest care. Resuscitation 2011, 82: 1168-1173. 10.1016/j.resuscitation.2011.05.024CrossRefPubMed Pfeifer R, Jung C, Purle S, Lauten A, Yilmaz A, Surber R, Ferrari M, Figulla HR: Survival does not improve when therapeutic hypothermia is added to post-cardiac arrest care. Resuscitation 2011, 82: 1168-1173. 10.1016/j.resuscitation.2011.05.024CrossRefPubMed
16.
go back to reference Storm C, Nee J, Roser M, Jörres A, Hasper D: Mild hypothermia treatment in patients resuscitated from non-shockable cardiac arrest. Emerg Med J 2012, 29: 100-103. 10.1136/emj.2010.105171CrossRefPubMed Storm C, Nee J, Roser M, Jörres A, Hasper D: Mild hypothermia treatment in patients resuscitated from non-shockable cardiac arrest. Emerg Med J 2012, 29: 100-103. 10.1136/emj.2010.105171CrossRefPubMed
17.
go back to reference Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, Janis LS, Wilde E, Taylor P, Harshman K, Conley A, Puccio A, Levin HS, McCauley SR, Bucholz RD, Smith KR, Schmidt JH, Scott JN, Yonas H, Okonkwo DO: Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol 2011, 10: 131-139. 10.1016/S1474-4422(10)70300-8PubMedCentralCrossRefPubMed Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, Janis LS, Wilde E, Taylor P, Harshman K, Conley A, Puccio A, Levin HS, McCauley SR, Bucholz RD, Smith KR, Schmidt JH, Scott JN, Yonas H, Okonkwo DO: Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol 2011, 10: 131-139. 10.1016/S1474-4422(10)70300-8PubMedCentralCrossRefPubMed
18.
go back to reference Gotberg M, Olivecrona GK, Koul S, Carlsson M, Engblom H, Ugander M, van der Pals J, Algotsson L, Arheden H, Erlinge D: A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction. Circ Cardiovasc Interv 2010, 3: 400-407. 10.1161/CIRCINTERVENTIONS.110.957902CrossRefPubMed Gotberg M, Olivecrona GK, Koul S, Carlsson M, Engblom H, Ugander M, van der Pals J, Algotsson L, Arheden H, Erlinge D: A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction. Circ Cardiovasc Interv 2010, 3: 400-407. 10.1161/CIRCINTERVENTIONS.110.957902CrossRefPubMed
19.
go back to reference Thurau K, Boylan JW: Acute renal success. The unexpected logic of oliguria in acute renal failure. Am J Med 1976, 61: 308-315. 10.1016/0002-9343(76)90365-XCrossRefPubMed Thurau K, Boylan JW: Acute renal success. The unexpected logic of oliguria in acute renal failure. Am J Med 1976, 61: 308-315. 10.1016/0002-9343(76)90365-XCrossRefPubMed
20.
go back to reference Stocker R, Yamamoto Y, McDonagh A, Glazer A, Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235: 1043-1045. 10.1126/science.3029864CrossRefPubMed Stocker R, Yamamoto Y, McDonagh A, Glazer A, Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235: 1043-1045. 10.1126/science.3029864CrossRefPubMed
22.
go back to reference Schurr A: Lactate: the ultimate cerebral oxidative energy substrate? J Cereb Blood Flow Metab 2006, 26: 142-152. 10.1038/sj.jcbfm.9600174CrossRefPubMed Schurr A: Lactate: the ultimate cerebral oxidative energy substrate? J Cereb Blood Flow Metab 2006, 26: 142-152. 10.1038/sj.jcbfm.9600174CrossRefPubMed
23.
go back to reference Shibata K, Cregg N, Engelberts D, Takeuchi A, Fedorko L, Kavanagh BP: Hypercapnic acidosis may attenuate lung injury by inhibition of endogenous xanthine oxidase. Am J Respir Crit Care Med 1998, 158: 1578-1584.CrossRefPubMed Shibata K, Cregg N, Engelberts D, Takeuchi A, Fedorko L, Kavanagh BP: Hypercapnic acidosis may attenuate lung injury by inhibition of endogenous xanthine oxidase. Am J Respir Crit Care Med 1998, 158: 1578-1584.CrossRefPubMed
25.
go back to reference Singer M, De Santis V, Vitale D, Jeffcoate W: Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004, 364: 545-548. 10.1016/S0140-6736(04)16815-3CrossRefPubMed Singer M, De Santis V, Vitale D, Jeffcoate W: Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004, 364: 545-548. 10.1016/S0140-6736(04)16815-3CrossRefPubMed
26.
go back to reference Brame AL, Singer M: Stressing the obvious? An allostatic look at critical illness. Crit Care Med 2010,38(10 Suppl):S600-S607.CrossRefPubMed Brame AL, Singer M: Stressing the obvious? An allostatic look at critical illness. Crit Care Med 2010,38(10 Suppl):S600-S607.CrossRefPubMed
27.
go back to reference Marini JJ: Can we prevent the spread of focal lung inflammation? Crit Care Med 2010,38(10 Suppl):S574-S581.CrossRefPubMed Marini JJ: Can we prevent the spread of focal lung inflammation? Crit Care Med 2010,38(10 Suppl):S574-S581.CrossRefPubMed
28.
go back to reference Selye H: A syndrome produced by diverse nocuous agents. Nature 1936, 138: 32.CrossRef Selye H: A syndrome produced by diverse nocuous agents. Nature 1936, 138: 32.CrossRef
29.
go back to reference Novotny N, Lahm T, Markel T, Crisostomo P, Wang M, Wang Y, Ray R, Tan J, Al-Azzawi D, Meldrum D: Beta-blockers in sepsis: reexamining the evidence. Shock 2009, 31: 113-119. 10.1097/SHK.0b013e318180ffb6CrossRefPubMed Novotny N, Lahm T, Markel T, Crisostomo P, Wang M, Wang Y, Ray R, Tan J, Al-Azzawi D, Meldrum D: Beta-blockers in sepsis: reexamining the evidence. Shock 2009, 31: 113-119. 10.1097/SHK.0b013e318180ffb6CrossRefPubMed
30.
go back to reference Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007, 298: 2644-2653. 10.1001/jama.298.22.2644CrossRefPubMed Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007, 298: 2644-2653. 10.1001/jama.298.22.2644CrossRefPubMed
31.
go back to reference Conrad C, Niess H, Jauch K-W, Bruns C, Hartl W, Welker L: Overture for growth hormone: requiem for interleukin-6? Crit Care Med 2007, 35: 2709-2713. 10.1097/01.CCM.0000291648.99043.B9CrossRefPubMed Conrad C, Niess H, Jauch K-W, Bruns C, Hartl W, Welker L: Overture for growth hormone: requiem for interleukin-6? Crit Care Med 2007, 35: 2709-2713. 10.1097/01.CCM.0000291648.99043.B9CrossRefPubMed
32.
go back to reference Xie H, Kang J, Mills GH: Clinical review: The impact of noise on patients' sleep and the effectiveness of noise reduction strategies in intensive care units. Crit Care 2009, 13: 208. 10.1186/cc7154PubMedCentralCrossRefPubMed Xie H, Kang J, Mills GH: Clinical review: The impact of noise on patients' sleep and the effectiveness of noise reduction strategies in intensive care units. Crit Care 2009, 13: 208. 10.1186/cc7154PubMedCentralCrossRefPubMed
33.
go back to reference Hudis CA: Trastuzumab -- mechanism of action and use in clinical practice. N Engl J Med 2007, 357: 39-51. 10.1056/NEJMra043186CrossRefPubMed Hudis CA: Trastuzumab -- mechanism of action and use in clinical practice. N Engl J Med 2007, 357: 39-51. 10.1056/NEJMra043186CrossRefPubMed
36.
go back to reference Ospina-Tascon GA, Buchele GL, Vincent JL: Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail? Crit Care Med 2008, 36: 1311-1322. 10.1097/CCM.0b013e318168ea3eCrossRefPubMed Ospina-Tascon GA, Buchele GL, Vincent JL: Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail? Crit Care Med 2008, 36: 1311-1322. 10.1097/CCM.0b013e318168ea3eCrossRefPubMed
37.
go back to reference Presneill JJ, Harris T, Stewart AG, Cade JF, Wilson JW: A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am J Respir Crit Care Med 2002, 166: 138-143. 10.1164/rccm.2009005CrossRefPubMed Presneill JJ, Harris T, Stewart AG, Cade JF, Wilson JW: A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am J Respir Crit Care Med 2002, 166: 138-143. 10.1164/rccm.2009005CrossRefPubMed
38.
go back to reference Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk H-D: Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009, 180: 640-648. 10.1164/rccm.200903-0363OCCrossRefPubMed Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk H-D: Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009, 180: 640-648. 10.1164/rccm.200903-0363OCCrossRefPubMed
39.
go back to reference Protti A, Singer M: Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care 2006, 10: 228. 10.1186/cc5014PubMedCentralCrossRefPubMed Protti A, Singer M: Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care 2006, 10: 228. 10.1186/cc5014PubMedCentralCrossRefPubMed
40.
go back to reference Ellger B, Debaveye Y, Van den Berghe G: Endocrine interventions in the ICU. Eur J Intern Med 2005, 16: 71-82. 10.1016/j.ejim.2004.10.014CrossRefPubMed Ellger B, Debaveye Y, Van den Berghe G: Endocrine interventions in the ICU. Eur J Intern Med 2005, 16: 71-82. 10.1016/j.ejim.2004.10.014CrossRefPubMed
Metadata
Title
Advancing critical care: time to kiss the right frog
Author
Mervyn Singer
Publication date
01-02-2013
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 1/2013
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc11501

Other articles of this Special Issue 1/2013

Critical Care 1/2013 Go to the issue